Apogee Therapeutics, Financials
APGE Stock | 48.38 0.69 1.41% |
Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
---|---|---|---|---|---|---|---|---|---|
Debt Equity Ratio | 0.0023 | 0.0026 |
|
| |||||
Current Ratio | 13.85 | 19.3798 |
|
|
Apogee |
Understanding current and past Apogee Therapeutics, Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Apogee Therapeutics,'s financial statements are interrelated, with each one affecting the others. For example, an increase in Apogee Therapeutics,'s assets may result in an increase in income on the income statement.
Please note, the presentation of Apogee Therapeutics,'s financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Apogee Therapeutics,'s management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Apogee Therapeutics,'s management manipulating its earnings.
Apogee Therapeutics, Stock Summary
Apogee Therapeutics, competes with Compania Cervecerias, Scandinavian Tobacco, Mill City, Encore Capital, and Boston Beer. Apogee Therapeutics, is entity of United States. It is traded as Stock on NASDAQ exchange.Specialization | Health Care, Pharmaceuticals, Biotechnology & Life Sciences |
Instrument | USA Stock View All |
Exchange | NASDAQ Exchange |
CUSIP | 03770N101 |
Location | Massachusetts; U.S.A |
Business Address | 221 Crescent Street, |
Sector | Biotechnology |
Industry | Health Care |
Benchmark | Dow Jones Industrial |
Website | www.apogeetherapeutics.com |
Phone | 650 394 5230 |
Apogee Therapeutics, Key Financial Ratios
Return On Equity | -0.26 | ||||
EBITDA | (83.98 M) | ||||
Net Income | (83.98 M) | ||||
Book Value Per Share | 12.55 X | ||||
Market Capitalization | 2.79 B |
Apogee Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Apogee Therapeutics,'s current stock value. Our valuation model uses many indicators to compare Apogee Therapeutics, value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Apogee Therapeutics, competition to find correlations between indicators driving Apogee Therapeutics,'s intrinsic value. More Info.Apogee Therapeutics, Common is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers . At present, Apogee Therapeutics,'s Return On Equity is projected to increase slightly based on the last few years of reporting. Comparative valuation analysis is a catch-all technique that is used if you cannot value Apogee Therapeutics, by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.Apogee Therapeutics, Systematic Risk
Apogee Therapeutics,'s systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Apogee Therapeutics, volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was fourty-two with a total number of output elements of nineteen. The Beta measures systematic risk based on how returns on Apogee Therapeutics, correlated with the market. If Beta is less than 0 Apogee Therapeutics, generally moves in the opposite direction as compared to the market. If Apogee Therapeutics, Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Apogee Therapeutics, is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Apogee Therapeutics, is generally in the same direction as the market. If Beta > 1 Apogee Therapeutics, moves generally in the same direction as, but more than the movement of the benchmark.
Apogee Therapeutics, Thematic Clasifications
Apogee Therapeutics, Common is part of Biotech investing theme. If you are a theme-oriented, socially responsible, and at the same time, a result-driven investor, you can align your investing habits with your values without jeopardizing your expectations about returns. You can easily create an optimal portfolio of stocks, ETFs, funds, or cryptocurrencies based on a specific theme of your liking. Biotechnology and pharmaceuticals production and services. Companies specialized in biotechnology production and delivery of pharmaceuticals services
This theme covers Biotechnology and pharmaceuticals production and services. Companies specialized in biotechnology production and delivery of pharmaceuticals services. Get More Thematic Ideas
Biotech | View |
Apogee Therapeutics, December 12, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Apogee Therapeutics, help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Apogee Therapeutics, Common. We use our internally-developed statistical techniques to arrive at the intrinsic value of Apogee Therapeutics, Common based on widely used predictive technical indicators. In general, we focus on analyzing Apogee Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Apogee Therapeutics,'s daily price indicators and compare them against related drivers.
Downside Deviation | 3.75 | |||
Information Ratio | (0.01) | |||
Maximum Drawdown | 21.79 | |||
Value At Risk | (5.21) | |||
Potential Upside | 5.62 |
Complementary Tools for Apogee Stock analysis
When running Apogee Therapeutics,'s price analysis, check to measure Apogee Therapeutics,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Apogee Therapeutics, is operating at the current time. Most of Apogee Therapeutics,'s value examination focuses on studying past and present price action to predict the probability of Apogee Therapeutics,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Apogee Therapeutics,'s price. Additionally, you may evaluate how the addition of Apogee Therapeutics, to your portfolios can decrease your overall portfolio volatility.
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins |